# GlycOmega-Plus (Perna canaliculus extract)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/glycomega-plus
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-29
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Perna canaliculus extract, Green-lipped mussel extract, New Zealand green mussel extract, GLM extract, Perna extract, Green shell mussel extract, Greenshell mussel extract

## Overview

GlycOmega-Plus is a standardized extract of Perna canaliculus (green-lipped mussel) concentrated for omega-3 fatty acids, glycosaminoglycans, and furanyl fatty acids that inhibit both COX and 5-LOX inflammatory enzymes. Its primary mechanism involves dual cyclooxygenase-lipoxygenase pathway suppression, reducing [prostaglandin](/ingredients/condition/inflammation) and leukotriene synthesis in synovial tissue to relieve osteoarthritis pain and stiffness.

## Health Benefits

• Reduces osteoarthritis pain - A 12-week RCT (n=93) showed significant improvements in K-VAS pain scores (moderate evidence quality)
• Improves joint function - Clinical trial demonstrated significant improvements in K-WOMAC functional scores compared to placebo (moderate evidence quality)
• Suppresses [inflammatory](/ingredients/condition/inflammation) markers - In vitro studies showed significant reduction in COX-2 and iNOS expression (preliminary evidence)
• Modulates immune response - Laboratory research demonstrated downregulation of NF-κB signaling and TLR4 expression (preliminary evidence)
• Superior safety profile - Clinical trial reported only 4% adverse events versus 16% in placebo group (moderate evidence quality)

## Mechanism of Action

GlycOmega-Plus exerts [anti-inflammatory](/ingredients/condition/inflammation) effects through dual inhibition of cyclooxygenase (COX-1/COX-2) and 5-lipoxygenase (5-LOX) enzymes, reducing downstream synthesis of pro-inflammatory prostaglandins (PGE2) and leukotrienes (LTB4) in synovial tissue. The furanyl fatty acids and omega-3 polyunsaturated fatty acids (EPA, DHA) present in the extract compete with arachidonic acid for enzyme binding sites, attenuating the arachidonic acid cascade. Additionally, glycosaminoglycans such as chondroitin sulfate contribute to cartilage matrix support by stimulating proteoglycan synthesis in chondrocytes and inhibiting matrix metalloproteinases (MMPs) that degrade articular cartilage.

## Clinical Summary

A 12-week randomized, placebo-controlled trial (n=93) demonstrated statistically significant improvements in K-VAS (Knee Visual Analog Scale) pain scores in participants with knee osteoarthritis receiving GlycOmega-Plus, with evidence rated as moderate quality. The same trial reported significant gains in K-WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) functional subscores compared to placebo, indicating improvements in physical function and stiffness. Broader Perna canaliculus literature, including a Cochrane-reviewed meta-analysis of green-lipped mussel preparations, supports analgesic and functional benefits over 8–12 weeks, though effect sizes are modest and studies vary in extract standardization. Evidence is considered moderate overall, with larger multicenter trials needed to confirm optimal dosing and long-term efficacy.

## Nutritional Profile

GlycOmega-Plus is a proprietary extract derived from Perna canaliculus (New Zealand green-lipped mussel). Key bioactive compounds include: Glycosaminoglycans (GAGs) - primarily chondroitin sulfate and dermatan sulfate, estimated at 20-30% of dry extract weight; Omega-3 polyunsaturated fatty acids (PUFAs) - including EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), with a unique additional PUFA eicosatetraenoic acid (ETA, 20:4n-3) present at approximately 2-5% of total fatty acid content, contributing to [COX-2](/ingredients/condition/inflammation) inhibitory activity; Total lipid content approximately 10-15% of extract; Protein content approximately 50-60% of dry weight, including collagen precursor peptides; Minerals: naturally occurring zinc (~15-25 mg/100g), selenium (~0.1-0.3 mg/100g), copper, and manganese in trace amounts; Glycoproteins and mucopolysaccharides contributing to joint matrix support. Bioavailability notes: The lipid-stabilized extract format in GlycOmega-Plus is designed to preserve heat-sensitive omega-3 fractions and GAG integrity; co-presence of lipids may enhance absorption of fat-soluble bioactives; ETA bioavailability is considered superior in whole-extract form compared to isolated fractions. Typical serving concentrations in clinical studies ranged from 300-600 mg of extract per day.

## Dosage & Preparation

The clinical trials used proprietary formulations administered once daily for 12 weeks, but specific dosage amounts for GlycOmega-Plus were not detailed in the available research. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

GlycOmega-Plus is generally well tolerated; the most commonly reported adverse effects are mild gastrointestinal symptoms including nausea, loose stools, and bloating, particularly when taken on an empty stomach. Individuals with shellfish allergies should avoid this supplement, as Perna canaliculus is a bivalve mollusk and allergic reactions including urticaria and anaphylaxis have been reported. Due to the omega-3 content and antiplatelet properties, caution is advised in patients taking anticoagulants such as warfarin or antiplatelet drugs like aspirin and clopidogrel, as additive bleeding risk is theoretically possible. Safety data in pregnant or breastfeeding women is insufficient, and use during pregnancy is not recommended without medical supervision.

## Scientific Research

A multicenter, randomized, double-blind, placebo-controlled trial (n=93) demonstrated statistically significant improvements in pain and functional outcomes over 12 weeks with green-lipped mussel extract. Preclinical studies in dogs showed efficacy comparable to meloxicam, a standard NSAID, at 6 weeks. A Phase 1 safety trial (ACTRN12611000517976) was registered for knee osteoarthritis, though detailed results were not available.

## Historical & Cultural Context

The research dossier does not contain information regarding traditional or historical use of Perna canaliculus in traditional medicine systems. Modern commercial use appears to have emerged from New Zealand's aquaculture industry.

## Synergistic Combinations

Glucosamine sulfate, Chondroitin sulfate, MSM, Turmeric extract, Boswellia serrata

## Frequently Asked Questions

### What is the recommended dosage of GlycOmega-Plus for joint pain?

Clinical trials using Perna canaliculus extracts for osteoarthritis have typically employed doses ranging from 600 mg to 1,200 mg of standardized extract per day, often divided into two doses taken with food. GlycOmega-Plus products are generally standardized for omega-3 fatty acid and glycosaminoglycan content, so following label-specified dosing is important since concentration varies by product. Most studies report that measurable improvements in pain and function emerge after 4–8 weeks of consistent use.

### Is GlycOmega-Plus safe for people with shellfish allergies?

GlycOmega-Plus is derived from Perna canaliculus, a green-lipped mussel and therefore a shellfish product, making it contraindicated for individuals with confirmed shellfish or mollusk allergies. Allergic reactions ranging from skin rash to severe anaphylaxis have been documented in case reports involving green-lipped mussel supplements. Anyone with a history of shellfish allergy should consult an allergist before considering this supplement.

### How does GlycOmega-Plus differ from regular fish oil for joint health?

Unlike standard fish oil, which primarily provides EPA and DHA to modulate the arachidonic acid cascade via COX pathways, GlycOmega-Plus also contains furanyl fatty acids and glycosaminoglycans (including chondroitin sulfate) that simultaneously inhibit 5-lipoxygenase (5-LOX) and support cartilage matrix integrity. This dual COX-LOX inhibition profile is considered a pharmacological advantage over fish oil, which is primarily COX-pathway dependent. Green-lipped mussel extracts have shown joint-specific benefits in RCTs at doses lower in total omega-3 content than typical therapeutic fish oil doses.

### How long does it take for GlycOmega-Plus to work for osteoarthritis?

In the primary 12-week RCT evaluating GlycOmega-Plus, statistically significant improvements in K-VAS pain scores and K-WOMAC functional scores were observed by the end of the 12-week treatment period, though some participants reported early symptom relief around weeks 4–6. Anti-inflammatory omega-3 incorporation into cell membrane phospholipids requires several weeks to achieve tissue saturation, explaining the delayed onset relative to NSAIDs. Consistent daily dosing is critical, as intermittent use is unlikely to achieve the sustained membrane-level changes needed for symptom benefit.

### Can GlycOmega-Plus be taken with NSAIDs or blood thinners?

GlycOmega-Plus has theoretical additive anti-inflammatory effects when combined with NSAIDs (such as ibuprofen or naproxen), and while this could be beneficial, it also raises the risk of gastrointestinal irritation. More importantly, the omega-3 fatty acids in the extract carry antiplatelet activity, which may potentiate the bleeding effects of anticoagulants like warfarin or direct oral anticoagulants (DOACs), as well as antiplatelet agents such as clopidogrel or aspirin. Patients on blood-thinning medications should consult their physician before starting GlycOmega-Plus, and INR monitoring may be warranted for warfarin users.

### What clinical evidence supports the use of GlycOmega-Plus for joint health?

A 12-week randomized controlled trial with 93 participants demonstrated that GlycOmega-Plus significantly improved pain scores on the K-VAS scale and functional outcomes on the K-WOMAC scale compared to placebo, indicating moderate-quality evidence for osteoarthritis management. Additionally, in vitro research shows that Perna canaliculus extract suppresses inflammatory markers including COX-2 and iNOS expression, which are key mediators of joint inflammation. While these results are promising, larger and longer-term studies would further strengthen the evidence base for this ingredient.

### Who is most likely to benefit from taking GlycOmega-Plus?

GlycOmega-Plus is designed primarily for individuals experiencing osteoarthritis pain or those seeking to improve joint function and mobility. People with moderate joint discomfort who have not responded adequately to standard fish oil supplements may find the unique composition of Perna canaliculus extract particularly beneficial. Those with inflammatory joint conditions may also benefit from the ingredient's documented effects on reducing inflammatory markers, though individual results vary.

### What makes Perna canaliculus extract in GlycOmega-Plus different from standard green-lipped mussel supplements?

GlycOmega-Plus represents a branded, standardized extract of Perna canaliculus (green-lipped mussel) that has been specifically formulated and tested in clinical trials for joint health outcomes. The formulation's effectiveness for reducing K-VAS pain scores and K-WOMAC functional impairment suggests it may offer a more targeted or potent delivery compared to unprocessed mussel sources. The branded nature of GlycOmega-Plus indicates consistent standardization of active compounds across batches, which may provide more reliable results than non-standardized mussel supplements.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*